Systems and methods for modulation of pancreatic endocrine secretion and treatment of diabetes
US6832114B1 · kind B1 · utility
410Cited by
27References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 6, 2001 |
| Grant date | Dec 14, 2004 |
| Priority date | — |
| Expiry date | Dec 1, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61N1/326
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
Systems and methods for introducing one or more stimulating drugs and/or applying electrical stimulation to the pancreas and/or nerve fibers innervating the pancreas to treat or prevent diabetes and/or to modulate pancreatic endocrine secretions uses at least one system control unit (SCU) producing electrical pulses delivered via electrodes and/or producing drug infusion pulses, wherein the stimulating drug(s) are delivered via one or more pumps and infusion outlets.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.